BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19118036)

  • 21. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
    Rettig I; Koeneke E; Trippel F; Mueller WC; Burhenne J; Kopp-Schneider A; Fabian J; Schober A; Fernekorn U; von Deimling A; Deubzer HE; Milde T; Witt O; Oehme I
    Cell Death Dis; 2015 Feb; 6(2):e1657. PubMed ID: 25695609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility.
    Waltregny D; Glénisson W; Tran SL; North BJ; Verdin E; Colige A; Castronovo V
    FASEB J; 2005 Jun; 19(8):966-8. PubMed ID: 15772115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells.
    Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y
    Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
    Krennhrubec K; Marshall BL; Hedglin M; Verdin E; Ulrich SM
    Bioorg Med Chem Lett; 2007 May; 17(10):2874-8. PubMed ID: 17346959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.
    Suzuki T; Ota Y; Ri M; Bando M; Gotoh A; Itoh Y; Tsumoto H; Tatum PR; Mizukami T; Nakagawa H; Iida S; Ueda R; Shirahige K; Miyata N
    J Med Chem; 2012 Nov; 55(22):9562-75. PubMed ID: 23116147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.
    Ajamian F; Salminen A; Reeben M
    Neurosci Lett; 2004 Jul; 365(1):64-8. PubMed ID: 15234474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors.
    Huang WJ; Wang YC; Chao SW; Yang CY; Chen LC; Lin MH; Hou WC; Chen MY; Lee TL; Yang P; Chang CI
    ChemMedChem; 2012 Oct; 7(10):1815-24. PubMed ID: 22907916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.
    Thangaraju M; Carswell KN; Prasad PD; Ganapathy V
    Biochem J; 2009 Jan; 417(1):379-89. PubMed ID: 18789002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
    Ortore G; Di Colo F; Martinelli A
    J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
    Song S; Wang Y; Xu P; Yang R; Ma Z; Liang S; Zhang G
    Int J Oncol; 2015 Nov; 47(5):1819-28. PubMed ID: 26412386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role for histone deacetylase 1 in human tumor cell proliferation.
    Senese S; Zaragoza K; Minardi S; Muradore I; Ronzoni S; Passafaro A; Bernard L; Draetta GF; Alcalay M; Seiser C; Chiocca S
    Mol Cell Biol; 2007 Jul; 27(13):4784-95. PubMed ID: 17470557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
    Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
    Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin.
    Li X; Yin S; Meng Y; Sakr W; Sheng S
    Cancer Res; 2006 Sep; 66(18):9323-9. PubMed ID: 16982778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profile of class I histone deacetylases in human cancer tissues.
    Nakagawa M; Oda Y; Eguchi T; Aishima S; Yao T; Hosoi F; Basaki Y; Ono M; Kuwano M; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2007 Oct; 18(4):769-74. PubMed ID: 17786334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.
    Kolbinger FR; Koeneke E; Ridinger J; Heimburg T; Müller M; Bayer T; Sippl W; Jung M; Gunkel N; Miller AK; Westermann F; Witt O; Oehme I
    Arch Toxicol; 2018 Aug; 92(8):2649-2664. PubMed ID: 29947893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137.
    Zhao G; Wang G; Bai H; Li T; Gong F; Yang H; Wen J; Wang W
    Eur J Pharmacol; 2017 May; 802():20-26. PubMed ID: 28223126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation.
    Glenisson W; Castronovo V; Waltregny D
    Biochim Biophys Acta; 2007 Oct; 1773(10):1572-82. PubMed ID: 17610967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
    Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
    Nat Genet; 2006 May; 38(5):566-9. PubMed ID: 16642021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.